
Vivo Capital
Global healthcare investment firm focused on catalyzing innovation and growth across venture, private equity, and public equity strategies.
About
Vivo Capital is a global healthcare specialist with a multi-strategy investment platform covering venture capital, private equity, and public equity. The firm seeks to support the expansion of healthcare access and catalyze innovation and growth through investments in biopharmaceuticals, specialty pharmaceuticals, medical devices, and other life sciences sectors. They invest in companies with promising development-stage and commercial-stage therapeutic products in the U.S.
Key facts
At-a-glance profile data
- Website
- vivocapital.com
- Type
- VC
- Headquarters
- Palo Alto, U.S.
- Funds raised
- $2.9B
- Portfolio companies
- 1
- Stages
- SeedSeries ASeries BGrowthBuyout
- Sector focus
- Agricultural ChemicalsDrug DiscoveryBiotechnologyPharmaceuticalsMedical Devices
Recent investments
| Date | Company | Round | Amount |
|---|---|---|---|
| 20 Mar 2026 | Earendil | Funding Round | $787M |
Add first review
Frequently asked
What companies has Vivo Capital invested in?
Vivo Capital has invested in Earendil, Earendil Labs.
AUM
$2.9B
PORTFOLIO
1